痴呆症护理研究和心理社会因素
Aiko Ishiki1, Chika Oyama1, Isabelle Miyazawa1
1Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
对早期阿尔茨海默氏症的莱卡尼马布的引入并没有增加早期诊断或患者转诊到日本的专家. 在初级保健医生和专家之间改善合作对于及时治疗阿尔茨海默病至关重要.
科学领域:
- 神经学 神经学
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 莱卡尼马布是一种抗粉样β药物,于2023年9月在日本批准用于早期阿尔茨海默病 (AD).
- 这项批准需要更早的阿尔茨海默病诊断,可能会增加向专业中心的转诊.
- 这项研究调查了在Lecanemab推出后的痴呆症疾病中心患者人口统计和诊断的变化.
研究的目的:
- 评估Lecanemab的可用性对日本痴呆症疾病中心患者转诊和特征的影响.
- 为了确定Lecanemab引入前后患者群体概况是否发生变化.
主要方法:
- 在日本东部的一个痴呆症疾病中心对2022年1月至2024年8月的患者数据 (n=409) 的分析.
- 患者人口统计,认知评估 (MMSE,FAST阶段) 和在Lecanemab前 (2023年1月之前) 和Lecanemab后期间的最终诊断的比较.
主要成果:
- 在Lecanemab推出前后的患者年龄,迷你精神状态检查 (MMSE) 评分或功能评估分期 (FAST) 评分中没有发现显著差异.
- 大多数患者 (90.3%) 被诊断为痴呆症或轻度认知障碍 (MCI),其中56%被诊断为AD或MCI.
结论:
- 尽管Lecanemab可用于早期AD,但没有观察到早期诊断或患者转诊到专业中心的增加.
- 初级保健医生和痴呆症专家之间的加强合作对于优化患者护理和治疗新疗法,如Lecanemab,至关重要.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
01:30Dementia
480
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
480
01:29Psychological and Sociocultural Causes of Schizophrenia
436
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
436
01:26Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
01:22Alzheimer's Disease: Treatment
736
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
736
01:30Cognitive Development During Adulthood
737
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
737
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K